Celgene (CELG) Announces Results from 282 Abstracts Including its Therapies and Pipeline Compounds to Be Presented at ASH
Tweet Send to a Friend
Celgene Corporation (NASDAQ: CELG) today announced that data from 282 abstracts, including more than 60 oral presentations, evaluating Celgene investigational ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
